Calumet Specialty Products Partners - CLMT Stock Forecast, Price & News

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.

Calumet Specialty Products Partners Price Performance

Shares of CLMT traded up $0.03 during mid-day trading on Tuesday, hitting $16.30. 130,539 shares of the company's stock were exchanged, compared to its average volume of 177,425. Calumet Specialty Products Partners has a 52 week low of $5.40 and a 52 week high of $17.43. The company has a market cap of $1.29 billion, a PE ratio of -9.18 and a beta of 2.19. The company has a 50-day simple moving average of $12.04 and a 200 day simple moving average of $13.45.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CLMT shares. Wells Fargo & Company boosted their target price on Calumet Specialty Products Partners from $27.00 to $29.00 and gave the company an "overweight" rating in a research note on Thursday, April 21st. StockNews.com upgraded shares of Calumet Specialty Products Partners from a "sell" rating to a "hold" rating in a report on Friday, May 13th. Finally, Cowen increased their price objective on shares of Calumet Specialty Products Partners from $18.00 to $20.00 and gave the stock an "outperform" rating in a research report on Tuesday, June 28th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, Calumet Specialty Products Partners presently has a consensus rating of "Moderate Buy" and an average target price of $23.50.

Insider Transactions at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, EVP Scott Obermeier purchased 6,350 shares of the stock in a transaction on Tuesday, August 9th. The shares were purchased at an average cost of $15.95 per share, for a total transaction of $101,282.50. Following the purchase, the executive vice president now owns 48,143 shares of the company's stock, valued at $767,880.85. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, Chairman Stephen P. Mawer bought 9,251 shares of the company's stock in a transaction that occurred on Friday, August 12th. The shares were acquired at an average price of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the acquisition, the chairman now owns 137,233 shares of the company's stock, valued at approximately $2,210,823.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Scott Obermeier bought 6,350 shares of the company's stock in a transaction that occurred on Tuesday, August 9th. The shares were bought at an average price of $15.95 per share, for a total transaction of $101,282.50. Following the acquisition, the executive vice president now directly owns 48,143 shares of the company's stock, valued at approximately $767,880.85. The disclosure for this purchase can be found here. Insiders have acquired a total of 25,852 shares of company stock valued at $415,170 over the last 90 days. 2.91% of the stock is owned by corporate insiders.